285 related articles for article (PubMed ID: 22750309)
1. Triiodothyronine may be possibly associated with better cognitive function and less extrapyramidal symptoms in chronic schizophrenia.
Ichioka S; Terao T; Hoaki N; Matsushita T; Hoaki T
Prog Neuropsychopharmacol Biol Psychiatry; 2012 Oct; 39(1):170-4. PubMed ID: 22750309
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of negative symptoms in outpatients with schizophrenia spectrum disorders treated with antipsychotics in routine clinical practice: findings from the CLAMORS study.
Bobes J; Arango C; Garcia-Garcia M; Rejas J;
J Clin Psychiatry; 2010 Mar; 71(3):280-6. PubMed ID: 19895779
[TBL] [Abstract][Full Text] [Related]
3. Neurocognitive effects of ziprasidone and related factors in patients with chronic schizophrenia undergoing usual care: a 12-month, open-label, flexible-dose, naturalistic observational trial.
Gibel A; Ritsner MS
Clin Neuropharmacol; 2008; 31(4):204-20. PubMed ID: 18670244
[TBL] [Abstract][Full Text] [Related]
4. Motoric neurological soft signs and psychopathological symptoms in schizophrenic psychoses.
Jahn T; Hubmann W; Karr M; Mohr F; Schlenker R; Heidenreich T; Cohen R; Schröder J
Psychiatry Res; 2006 Jun; 142(2-3):191-9. PubMed ID: 16650902
[TBL] [Abstract][Full Text] [Related]
5. The relationship between depressive symptoms and subjective well-being in newly admitted patients with schizophrenia.
Kim JH; Ann JH; Kim MJ
Compr Psychiatry; 2010; 51(2):165-70. PubMed ID: 20152297
[TBL] [Abstract][Full Text] [Related]
6. Serum levels of brain-derived neurotrophic factor and cortisol to sulfate of dehydroepiandrosterone molar ratio associated with clinical response to L-theanine as augmentation of antipsychotic therapy in schizophrenia and schizoaffective disorder patients.
Miodownik C; Maayan R; Ratner Y; Lerner V; Pintov L; Mar M; Weizman A; Ritsner MS
Clin Neuropharmacol; 2011; 34(4):155-60. PubMed ID: 21617527
[TBL] [Abstract][Full Text] [Related]
7. Decreased BDNF in serum of patients with chronic schizophrenia on long-term treatment with antipsychotics.
Tan YL; Zhou DF; Cao LY; Zou YZ; Zhang XY
Neurosci Lett; 2005 Jul 1-8; 382(1-2):27-32. PubMed ID: 15911116
[TBL] [Abstract][Full Text] [Related]
8. Gender difference in association of cognition with BDNF in chronic schizophrenia.
Zhang XY; Chen DC; Tan YL; Tan SP; Wang ZR; Yang FD; Xiu MH; Hui L; Lv MH; Zunta-Soares GB; Soares JC
Psychoneuroendocrinology; 2014 Oct; 48():136-46. PubMed ID: 24999831
[TBL] [Abstract][Full Text] [Related]
9. Community dysfunction in schizophrenia: rate-limiting factors.
Bozikas VP; Kosmidis MH; Kafantari A; Gamvrula K; Vasiliadou E; Petrikis P; Fokas K; Karavatos A
Prog Neuropsychopharmacol Biol Psychiatry; 2006 May; 30(3):463-70. PubMed ID: 16442195
[TBL] [Abstract][Full Text] [Related]
10. Predictors of subjective and objective quality of life in outpatients with schizophrenia.
Yamauchi K; Aki H; Tomotake M; Iga J; Numata S; Motoki I; Izaki Y; Tayoshi S; Kinouchi S; Sumitani S; Tayoshi S; Takikawa Y; Kaneda Y; Taniguchi T; Ishimoto Y; Ueno S; Ohmori T
Psychiatry Clin Neurosci; 2008 Aug; 62(4):404-11. PubMed ID: 18778437
[TBL] [Abstract][Full Text] [Related]
11. Low serum levels of brain-derived neurotrophic factor in patients with schizophrenia do not elevate after antipsychotic treatment.
Pirildar S; Gönül AS; Taneli F; Akdeniz F
Prog Neuropsychopharmacol Biol Psychiatry; 2004 Jul; 28(4):709-13. PubMed ID: 15276697
[TBL] [Abstract][Full Text] [Related]
12. Effect of antipsychotic replacement with quetiapine on the symptoms and quality of life of schizophrenic patients with extrapyramidal symptoms.
Taniguchi T; Sumitani S; Aono M; Iga J; Kinouchi S; Aki H; Matsushita M; Taniguchi K; Tsuno M; Yamanishi K; Tomotake M; Kaneda Y; Ohmori T
Hum Psychopharmacol; 2006 Oct; 21(7):439-45. PubMed ID: 17029303
[TBL] [Abstract][Full Text] [Related]
13. Effects of tapering of long-term benzodiazepines on cognitive function in patients with schizophrenia receiving a second-generation antipsychotic.
Kitajima R; Miyamoto S; Tenjin T; Ojima K; Ogino S; Miyake N; Fujiwara K; Funamoto Y; Arai J; Tsukahara S; Ito Y; Tadokoro M; Anai K; Kaneda Y; Yamaguchi N
Prog Neuropsychopharmacol Biol Psychiatry; 2012 Mar; 36(2):300-6. PubMed ID: 22122880
[TBL] [Abstract][Full Text] [Related]
14. Blood Biomarkers Predict the Cognitive Effects of Aripiprazole in Patients with Acute Schizophrenia.
Hori H; Yoshimura R; Katsuki A; Atake K; Igata R; Konishi Y; Beppu H; Tominaga H
Int J Mol Sci; 2017 Mar; 18(3):. PubMed ID: 28272307
[TBL] [Abstract][Full Text] [Related]
15. [Changes in positive and negative symptoms, general psychopathology in schizophrenic patients during augmentation of antipsychotics with glycine: a preliminary 10-week open-label study].
Strzelecki D; Rabe-Jabłońska J
Psychiatr Pol; 2011; 45(6):825-37. PubMed ID: 22335126
[TBL] [Abstract][Full Text] [Related]
16. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
[TBL] [Abstract][Full Text] [Related]
17. Effect of bromocriptine on antipsychotic drug-induced hyperprolactinemia: eight-week randomized, single-blind, placebo-controlled, multicenter study.
Lee MS; Song HC; An H; Yang J; Ko YH; Jung IK; Joe SH
Psychiatry Clin Neurosci; 2010 Feb; 64(1):19-27. PubMed ID: 19968833
[TBL] [Abstract][Full Text] [Related]
18. Increased serum levels of brain-derived neurotrophic factor in chronic institutionalized patients with schizophrenia.
Reis HJ; Nicolato R; Barbosa IG; Teixeira do Prado PH; Romano-Silva MA; Teixeira AL
Neurosci Lett; 2008 Jul; 439(2):157-9. PubMed ID: 18514407
[TBL] [Abstract][Full Text] [Related]
19. Testosterone in first-episode schizophrenia.
Cesková E; Prikryl R; Kaspárek T
Neuro Endocrinol Lett; 2007 Dec; 28(6):811-4. PubMed ID: 18063925
[TBL] [Abstract][Full Text] [Related]
20. A pilot study on the relationship between thyroid status and neuropsychiatric symptoms in patients with Alzheimer disease.
Zhang N; Du HJ; Wang JH; Cheng Y
Chin Med J (Engl); 2012 Sep; 125(18):3211-6. PubMed ID: 22964311
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
